Modulation of oral bioavailability of anticancer drugs: from mouse to manJan H.M. Schellens, Jos H. Beijnen, Mirte M. Malingré et al.|European Journal of Pharmaceutical Sciences|2000Cited by 148
Phase I and Pharmacokinetic Study of Oral PaclitaxelMirte M. Malingré, Jan H.M. Schellens, W.W. ten Bokkel Huinink et al.|Journal of Clinical Oncology|2000Cited by 100
The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patientsMirte M. Malingré, Jos H. Beijnen, J. Schellens et al.|British Journal of Cancer|2001Cited by 72
Entrapment by Cremophor EL decreases the absorption of paclitaxel from the gutHeleen A. Bardelmeijer, Olaf van Tellingen, Mariët Ouwehand et al.|Cancer Chemotherapy and Pharmacology|2001Cited by 63
A phase I and pharmacokinetic study of bi-daily dosing of oral paclitaxel in combination with cyclosporin AMirte M. Malingré, Jan H.M. Schellens, Jos H. Beijnen et al.|Cancer Chemotherapy and Pharmacology|2001Cited by 43